Primary drug |
Number of clients using primary drug |
Opioids |
Cocaine |
Other stimulants |
Hypnotics, sedatives |
Hallucinogens |
Volatile inhalants |
Cannabis |
Alcohol |
Others |
|---|---|---|---|---|---|---|---|---|---|---|
Opioids |
235099 |
5.3 |
33.4 |
6.7 |
11.8 |
1.7 |
0.1 |
28.4 |
10.5 |
0.4 |
Cocaine |
31364 |
28.6 |
2.5 |
13.5 |
3.4 |
1.7 |
0.1 |
31.6 |
17.4 |
0.7 |
Cannabis |
21378 |
14.0 |
19.8 |
19.5 |
3.0 |
2.9 |
0.9 |
0.1 |
38.2 |
1.6 |
Stimulants |
10397 |
11.7 |
12.1 |
9.2 |
5.7 |
2.7 |
0.8 |
43.4 |
14.8 |
1.5 |
Notes: Data on secondary drug use are only collected for all treatment clients and not separately for new treatment clients. Opioids include: heroin, methadone, other opioids; cocaine includes: Cocaine CIH, crack cocaine; stimulants include: amphetamines, MDMA and derivates, other stimulants: cannabis can include herbal cannabis or cannabis resin. For each client up to four secondary drugs can be reported. A number of the clients report using the same drug both as primary and secondary drug, particularly for cannabis. Clients may report using different sub-types of the same substance, as defined in the TDI Protocol for the drugs categories. The greater part of clients using cannabis both as primary and secondary drug comes from Germany. See also 'General notes for interpreting data' on the Explanatory notes and help page. Source: | ||||||||||